103181-68-6

Basic information

• Product Name: Thiazolidine, 2-((2-methoxyphenoxy)methyl)-
• Synonyms: 2-((2-Methoxyphenoxy)methyl)thiazolidine;Thiazolidine, 2-((2-methoxyphenoxy)methyl)-
• CAS NO: 103181-68-6
• Molecular Formula: C₁₁H₁₅NO₂S
• Molecular Weight: 225.311
• EINECS: 1806241-263-5
• Mol File: 103181-68-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 359.6 °C at 760 mmHg
• Flash Point: 171.3 °C
• Appearance: /
• Density: 1.139 g/cm³
• Vapor Pressure: 2.36E-05mmHg at 25°C
• Refractive Index: 1.549
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Thiazolidine, 2-((2-methoxyphenoxy)methyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Thiazolidine, 2-((2-methoxyphenoxy)methyl)-(103181-68-6)
• EPA Substance Registry System: Thiazolidine, 2-((2-methoxyphenoxy)methyl)-(103181-68-6)

Safety Data

• Hazardous Substances Data: 103181-68-6(Hazardous Substances Data)

Usage

General Description

Thiazolidine, 2-((2-methoxyphenoxy)methyl)- is a chemical compound with the molecular formula C11H15NO2S. It is a thiazolidine derivative that contains a methoxyphenoxy group. Thiazolidine, 2-((2-methoxyphenoxy)methyl)- has potential applications in the pharmaceutical industry, particularly in the development of drugs for various therapeutic purposes. It has been studied for its anti-inflammatory and anti-tumor properties, as well as for its potential use in the treatment of diabetes and other metabolic disorders. Further research is warranted to explore the full range of potential applications for this compound.

InChI:InChI=1/C11H15NO2S/c1-13-9-4-2-3-5-10(9)14-8-11-12-6-7-15-11/h2-5,11-12H,6-8H2,1H3

Upstream product

• 18167-91-4 2(2-methoxyphenoxy)ethanale 
• 156-57-0 2-mercaptoethylamine hydrochloride 
• 1160183-64-1 2-[(2-methoxyphenoxy)methyl]-1,3-dioxolane 
• 161364-38-1 2-(2-methoxyphenoxy)acetaldehyde diethyl acetal 

Downstream Products

• 103182-67-8 3-(acetylaminoacetyl)-2-(O-methoxyphenoxy)methyl-thiazolidine 
• 119637-67-1 2-[2-methoxy-phenoxymethyl)-3-ethoxycarbonylacetyl-1,3-thiazolidine 
• 15647-89-9 triphenylphosphine hydrochloride 
• 103182-50-9 3-acryloyl-2-(O-hydroxyphenoxy)methyl-thiazolidine 
• 126128-00-5 2-<(2-methoxyphenoxy)methyl>-β-oxo-1,3-thiazolidine-3-propionic acid 
• 103181-71-1 2-<(2-methoxyphenoxy)methyl>-3-(2-chloroacetyl)-1,3-thiazolidine 
• 103182-18-9 2-<(2-methoxyphenoxy)methyl>-3-acetyl-1,3-thiazolidine 
• 103182-39-4 ethyl 2-<(2-methoxyphenoxy)methyl>-γ-oxo-1,3-thiazolidine-3-butyrate 
• 161364-68-7 ethyl 2-<(2-methoxyphenoxy)methyl>-α,α-dimethyl-β-oxo-1,3-thiazolidine-3-propionate 

Relevant articles and documents

New process for the synthesis of moguisteine

The invention relates to a process for the synthesis of moguisteine that is ethyl ester of (R,S)-3-[2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl]-3-oxypropanoic acid which comprises the steps of forming a new cyclic intermediate of formula 2-[(2-methoxyphenoxy)methyl]-1,3-dioxolane (4), forming (R,S)-2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidine (6) and reacting this latter with monoethylmalonic acid (7) or a salt thereof. The moguisteine of the invention is obtained in high yield and purity.

Antitussive and mucus regulating 2-substituted thiazolidines

2-Substituted thiazolidines compounds having formula I STR1 wherein X is a CH2, O or S, R is hydroxy or an acyloxy, alkyloxy, alkenyloxy or alkinyloxy group, R1 is hydrogen or a group of formula STR2 R2 is hydrogen or a free or esterified carboxy group, Ra and Rb are hydrogen or methyl, p is zero or 1, R3 is a C1 -C2 alkylsulphonyl group, a phenyl or p-Cl phenyl, p-methylsulphonyl group or an acyl group; are useful as mucus regulating, antitussive and antibronchospastic agents.